Neximmune to present at the raymond james 2021 human health innovation conference

Gaithersburg, md., june 16, 2021 (globe newswire) -- neximmune, inc. (nasdaq: nexi), a clinical-stage biotechnology company developing a novel approach to immunotherapy designed to orchestrate a targeted immune response by directing the function of antigen-specific t cells, today announced that scott carmer, chief executive officer, will present a company overview at the virtual 2021 human health innovation conference on tuesday, june 22, 2021 at 9:20 a.m. eastern time.
NEXI Ratings Summary
NEXI Quant Ranking